biocompatibility


Also found in: Dictionary, Medical, Wikipedia.

biocompatibility

[‚bī·ō·kəm‚pad·ə′bil·əd·ē]
(physiology)
The condition of being compatible with living tissue by virtue of a lack of toxicity or ability to cause immunological rejection.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
"Mono-Coat 1989W meets all requirements on biocompatibility and is therefore ideally suited for use in medical applications.
Biocompatibility refers to materials that can function well and is compatible with surrounding tissues.
Because of its good biocompatibility, PHBHHx is attracting increasing attention as a cell scaffold for tissue engineering (2).
Food & Drug Administration biocompatibility guidelines.
“We worked closely with Metric, providing guidance related to selection of the Makrolon polycarbonate grade that best met the stringent requirements - including toughness and biocompatibility - for this application,” said Fred Woods, field market development, Polycarbonate, Bayer MaterialScience LLC.
Calcium phosphate (CaP) and collagen are the main constituents of natural bone, and therefore gelatin - a denatured form of collagen - has excellent biodegradability and biocompatibility properties.
They cover biocompatibility in medical devices, evaluating and characterizing biocompatibility in medical devices, testing and interpreting the performance of medical devices, the international regulation of medical devices, and histopathology principles for biocompatibility and performance studies.
This key principle opens up new expectations for various biological events such as bioactivity, biocompatibility, host immune responses, etc.
It moves systematically from the fundamentals of textile materials and their fabrication through biocompatibility and biodegradability to the applications of textiles in healthcare, ranging from hygiene to wound care, grafts and implantables.
Materials included under the policy have been assessed for biocompatibility, are covered by an FDA Drug or Device Master File, and are subject to formula lock and a stringent change management process.
(BTX) announced the successful completion of ISO 10993 biocompatibility studies for HyStem-Rx.
The CE Mark approval was received following a review of the company's multi-centre European clinical study and its portfolio of biocompatibility and biomechanical testing.